MBX Biosciences MBX
NASDAQ MBX
$48.50 -1.96 (-3.88%)
At close: Oct 23, 2026 · 4:00 PM EDT

MBX Biosciences (MBX) Sale and Maturity of Investments (2023 - 2026)

Updated

Analysis

MBX Biosciences (MBX) Sale and Maturity of Investments (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 MBX Biosciences 2.33 Bn 701.63 Mn - 84.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 84.00 Mn
Mar 31, 2026 57.50 Mn
Dec 31, 2025 76.25 Mn
Sep 30, 2025 61.35 Mn
Jun 30, 2025 73.12 Mn
Mar 31, 2025 57.15 Mn
Dec 31, 2024 20.25 Mn
Sep 30, 2024 27.00 Mn
Jun 30, 2024 8.25 Mn
Mar 31, 2024 24.25 Mn
Dec 31, 2023 5.00 Mn
API Access

MBX Biosciences Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=MBX&period=max&api_key=YOUR_API_KEY